Schistosoma mansoni infection and hepatocellular carcinoma: a comorbidity study
Background The implication of human Schistosoma mansoni ( S. mansoni ) infection in concomitance with other risk factors such as hepatitis C virus (HCV) and hepatitis B virus (HBV) in the development of hepatocellular carcinoma (HCC) is still under controversy. This work aimed. to evaluate the role...
Gespeichert in:
Veröffentlicht in: | Journal of parasitic diseases 2024-12, Vol.48 (4), p.936-943 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background
The implication of human
Schistosoma mansoni
(
S. mansoni
) infection in concomitance with other risk factors such as hepatitis C virus (HCV) and hepatitis B virus (HBV) in the development of hepatocellular carcinoma (HCC) is still under controversy. This work aimed. to evaluate the role of
S. mansoni
infection in association with hepatitis B virus (HBV), hepatitis C virus (HCV) and other risk factors in the development and/or progress of HCC.
Methods
The present study was carried out on 90 HCC patients recruited from Kafr El-Sheikh Liver Disease Research Institute. After obtaining their informed consents, socio-demographic and clinical data were collected and patients were examined for
S. mansoni
by Kato-Katz and indirect hemagglutination (IHA) techniques. Alpha-fetoprotein (AFP) level was determined. The Child-Pugh scoring system and Barcelona Clinic Liver Cancer (BCLC) staging system were used to evaluate the pathological features of the studied patients.
Results
All participants were negative for active
S. mansoni
by Kato-Katz. Based on IHA, the participants were categorized into two groups: group I: sixty-two patients negative for
S. mansoni
and group II: twenty-eight schistosomiasis positive. The patients’ age ranged between 40->60, HCC was more prevalent in the age range of > 50–60 years in both groups. Males were more than females and rural participants were more than urban patients in both groups. Most of the patients (88.9%) had HCV while 7.8% had HBV. A higher proportion of HCC patients showed concomitant HCV and
S. mansoni
(92.6%) than the
S. mansoni
negative group. The frequency of upper gastrointestinal bleeding (GIB) was four-fold higher among HCC patients positive for schistosomiasis compared to negative schistosomiasis cases (64% vs. 16%). Alpha-fetoprotein (AFP) level was higher in group II than that in group I with no significant difference. Statistical analysis showed no difference between the two studied groups regarding Child scores. On the contrary, BCLC class D was significantly higher among HCC positive schistosomiasis cases compared to the negative group.
Conclusion
Concomitant
S. mansoni
with HCV and HBV potentiate HCC progression. |
---|---|
ISSN: | 0971-7196 0975-0703 |
DOI: | 10.1007/s12639-024-01721-y |